Journalartikel

Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension


AutorenlisteKeranov, Stanislav; Doerr, Oliver; Jafari, Leili; Liebetrau, Christoph; Keller, Till; Troidl, Christian; Riehm, Jessica; Rutsatz, Wiebke; Bauer, Pascal; Kriechbaum, Steffen; Voss, Sandra; Richter, Manuel J.; Tello, Khodr; Gall, Henning; Ghofrani, Hossein A.; Guth, Stefan; Seeger, Werner; Hamm, Christian W.; Nef, Holger

Jahr der Veröffentlichung2021

Seiten1021-1034

ZeitschriftBiomarkers in Medicine

Bandnummer15

Heftnummer12

ISSN1752-0363

eISSN1752-0371

DOI Linkhttps://doi.org/10.2217/bmm-2021-0009

VerlagTaylor and Francis


Abstract
Aim: This study assessed the utility of osteopontin (OPN) and galectin-3 (Gal-3) as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension (PH). Materials & methods: We examined plasma levels of OPN and Gal-3 in patients with PH (n = 62), dilated cardiomyopathy (n = 34), left ventricular hypertrophy (LVH; n = 47), and controls without right ventricle (RV) or LV abnormalities (n = 38). Results: OPN and Gal-3 levels were higher in PH, dilated cardiomyopathy and LVH than in the controls. OPN concentrations in PH patients with maladaptive RV were significantly higher than in those with adaptive RV. Gal-3 did not differentiate between adaptive and maladaptive RV remodeling in PH. OPN and Gal-3 levels did not correlate with parameters of LV remodeling. Conclusion: OPN is a potential biomarker of RV maladaptation.



Zitierstile

Harvard-ZitierstilKeranov, S., Doerr, O., Jafari, L., Liebetrau, C., Keller, T., Troidl, C., et al. (2021) Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension, Biomarkers in Medicine, 15(12), pp. 1021-1034. https://doi.org/10.2217/bmm-2021-0009

APA-ZitierstilKeranov, S., Doerr, O., Jafari, L., Liebetrau, C., Keller, T., Troidl, C., Riehm, J., Rutsatz, W., Bauer, P., Kriechbaum, S., Voss, S., Richter, M., Tello, K., Gall, H., Ghofrani, H., Guth, S., Seeger, W., Hamm, C., & Nef, H. (2021). Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension. Biomarkers in Medicine. 15(12), 1021-1034. https://doi.org/10.2217/bmm-2021-0009



Schlagwörter


CTEPHDCMFIBROSISHEART-FAILUREIPAHLV-hypertrophyRV-PA coupling


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:19